Article
Transformation from EGFR/PTEN co-mutated lung adenocarcinoma to small cell carcinoma in lymph node metastasis.
Pathology international - 1 May 2020
Hayashi Takuo, Takamochi Kazuya, Kohsaka Shinji, Kishikawa Satsuki, Suehara Yoshiyuki, Takahashi Fumiyuki, Suzuki Kenji, Saito Tsuyoshi, Yao Takashi
Abstract excerpt
There is minimal evidence of EGFR-mutated lung adenocarcinoma transforming to small cell lung carcinoma (SCLC) without the administration of EGFR-tyrosine kinase inhibitor (TKI). Here, we present a case of EGFR/PTEN co-mutated lung adenocarcinoma with lymph node metastases, which comprised adenocarcinoma admixed with SCLC. EGFR L858R and PTEN R130Q mutations were shared between the primary tumor and lymph node...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
